It is more common than you might think for women to suffer from major depressive disorder. However, depression can and should be treated. Please view this infographic to learn more…
By identifying the presence of the gene variations in HLA-B*1502 and HLA-A*3101, the GeneSight® Psychotropic pharmacogenomic test can predict if a patient may be at an increased risk of severe…
The GeneSight Psychotropic Test and “Use as Directed” Results Sometimes, a GeneSight® Psychotropic test report will show all medications in the “Use as Directed” column. This occurs in approximately 0.7%…
Treating Depression How the human body responds to the medications used to treat depression is very complicated. First, there’s a lot we don’t know about depression. According to Harvard Health:…
One of the most frequently asked questions from our patients is how to interpret the GeneSight report. The pharmacogenomic report contains a lot of useful, yet complex, information that may…
You’ve taken the GeneSight® test and have the results in hand. Your healthcare provider has likely reviewed the patient results pages with you and made recommendations on which medications may…
How do we know that the GeneSight® test is effective? There are multiple published studies showing the clinical validity and utility, as well as the economic utility, of the GeneSight…
Pharmacogenomics (phar·ma·co·ge·no·mics) may be a multisyllabic, hard-to-pronounce word. However, the relatively new field already has helped many, many people. What is Pharmacogenomics? When you go to see your healthcare provider…
What is MTHFR and why is it important? MTHFR is an enzyme required to convert folic acid into an active form called L-methylfolate that is usable by our bodies. L-methylfolate…